Advanced search
Publication Cover
Nutrition and Cancer Volume 72, 2020 - Issue 4
Submit an article Journal homepage
1,998
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Anticancer Characteristics of Fomitopsis pinicola Extract in a Xenograft Mouse Model—a Preliminary Study

Chi H. J. KaoDiscipline of Nutrition, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand; Correspondence[email protected]
View further author information
,
David R. GreenwoodSchool of Biological Sciences, University of Auckland, Auckland, New Zealand; View further author information
,
Stephen M. F. JamiesonAuckland Cancer Society Research Centre, University of Auckland, Auckland, New Zealand; View further author information
,
Margaret E. CoeLiggins Institute, University of Auckland, Auckland, New ZealandView further author information
,
Pamela M. MurrayAuckland Cancer Society Research Centre, University of Auckland, Auckland, New Zealand; View further author information
,
Lynnette R. FergusonDiscipline of Nutrition, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand; View further author information
&
Karen S. BishopAuckland Cancer Society Research Centre, University of Auckland, Auckland, New Zealand; ORCID Iconhttp://orcid.org/0000-0003-4935-7708View further author information
ORCID Icon show all
Pages 645-652 | Received 31 Jan 2019, Accepted 22 Jul 2019, Published online: 07 Aug 2019

References

  • Lindequist U, Niedermeyer THJ, and Jülich W-D: The pharmacological potential of mushrooms. Evid Based Complement Alternat Med 2, 285–299, 2005.
  • Feeney MJ, Dwyer J, Hasler-Lewis CM, Milner JA, Noakes M, et al. Mushrooms and health summit proceedings. J Nutr 144, 1128S–1136S, 2014.
  • Wasser SP, Nevo E, Sokolov D, Reshetnikov S, and Timot-Tismenetsky M: Dietary supplements from medicinal mushrooms: diversity of types and variety of regulations. Int J Med Mushr 2, 19, 2000.
  • Patel S and Goyal A: Recent developments in mushrooms as anti-cancer therapeutics: a review. 3 Biotech 2, 1–15, 2012.
  • Kao CH, Bishop KS, Xu Y, Han DY, Murray PM, et al. Identification of potential anticancer activities of novel ganoderma lucidum extracts using gene expression and pathway network analysis. Genomics Insights 9, 1–16, 2016.
  • Vaidyanathan V, Karunasinghe N, Krishnamurthy V, Kao CH, Naidu V, et al. Aggressive prostate cancer incidence in New Zealand“united we fall, divided we stand-”. N Z Med J 130, 96–99, 2017.
  • Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, et al. Global cancer statistics 2018: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68, 394–424, 2018.
  • Brinkmann AO: Molecular mechanisms of androgen action – a historical perspective. Methods Mol Biol 776, 3–24, 2011.
  • Ross RK, Pike MC, Coetzee GA, Reichardt JK, Yu MC, et al. Androgen metabolism and prostate cancer: establishing a model of genetic susceptibility. Cancer Res 58, 4497–4504, 1998.
  • Laurie N, Mohan A, McEvoy J, Reed D, Zhang J, et al. Changes in retinoblastoma cell adhesion associated with optic nerve invasion. Mol Cell Biol 29, 6268–6282, 2009.
  • Bostwick DG: The pathology of early prostate cancer. CA Cancer J Clin 39, 376–393, 1989.
  • Alimirah F, Chen J, Basrawala Z, Xin H, and Choubey D: Du-145 and pc-3 human prostate cancer cell lines express androgen receptor: implications for the androgen receptor functions and regulation. FEBS Lett 580, 2294–2300, 2006.
  • Grabowska MM, DeGraff DJ, Yu X, Jin RJ, Chen Z, et al. Mouse models of prostate cancer: Picking the best model for the question. Cancer Metastasis Rev 33, 377–397, 2014.
  • Wu X, Gong S, Roy-Burman P, Lee P, and Culig Z: Current mouse and cell models in prostate cancer research. Endocr-Relat Cancer 20, 10.1530/ERC-1512-0285, 2013.
  • Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative pcr and the 2(-delta delta c(t)) method. Methods 25, 402–408, 2001.
  • Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, et al. New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 82, 1107–1112, 1990.
  • Savjani KT, Gajjar AK, and Savjani JK: Drug solubility: importance and enhancement techniques. ISRN Pharm 2012, 1957272012.
  • Wu HT, Lu FH, Su YC, Ou HY, Hung HC, et al. In vivo and in vitro anti-tumor effects of fungal extracts. Molecules 19, 2546–2556, 2014.
  • Wang Y, Cheng X, Wang P, Wang L, Fan J, et al. Investigating migration inhibition and apoptotic effects of fomitopsis pinicola chloroform extract on human colorectal cancer sw-480 cells. PLoS One 9, e101303, 2014.
  • Gao Y, Wang P, Wang Y, Wu L, Wang X, et al. In vitro and in vivo activity of Fomitopsis pinicola (sw. Ex fr.) karst chloroform (fpkc) extract against s180 tumor cells. Cell Physiol Biochem 44, 2042–2056, 2017.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.